Brenton Scott
Founder at Pulmotect, Inc.
Net worth: 5 M $ as of 29/04/2024
Profile
Brenton Scott has founded two companies, Bondwell Technologies, Inc. in 2017 and Pulmotect, Inc. in 2007, where he holds the title of President & Chief Operating Officer.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
12/02/2023 | 21,185,283 ( 25.41% ) | 5 M $ | 29/04/2024 |
Brenton Scott active positions
Companies | Position | Start |
---|---|---|
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Founder | 31/12/2006 |
Former positions of Brenton Scott
Companies | Position | End |
---|---|---|
Bondwell Technologies, Inc.
Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Health Technology |
Bondwell Technologies, Inc.
Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Health Technology |
- Stock Market
- Insiders
- Brenton Scott